Remember meForgot password?
    Log in with Twitter
Press Release

Aug 10, 2017 11:28 UTC

Cancer Vaccines Market to Reach $12.8 Billion by 2023: Analysis By Technology, Type, Indication, End Use & Geography - Research and Markets

DUBLIN--(Business Wire)--The "Cancer Vaccines Market by Technology - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to Research and Markets' offering.

The global cancer vaccines market was valued at $4,073 million in 2016, and is expected to reach at $12,814 million by 2023, registering a CAGR of 17.7% from 2017 to 2023.

The key factors that driving the market growth include rise in prevalence of human papilloma virus (HPV) infections leading to cancers, increase in administration of prophylactic cancer vaccines, surge in investments in the development of cancer vaccines by manufacturers & governmental funding, and launch & approval of novel cancer vaccines in the market.

The global cancer vaccines market is segmented based on technology, indication, type end use, and region. Based on technology, it is categorized into dendritic cells (DC) cancer vaccines, recombinant cancer vaccines, antigen/adjuvant cancer vaccines, whole cell cancer vaccines, and viral vector & DNA cancer vaccines. Based on indication, it is bifurcated into cervical cancer, prostate cancer, and others. On the basis of end use, it is classified into pediatric vaccines and adult vaccines. Based on type, the market is divided into therapeutic cancer vaccines and preventive cancer vaccines.

Companies Mentioned

  • AstraZeneca PLC. (Medimmune, LLC.)
  • Glaxosmithkline Plc.
  • Merck & Co., Inc.
  • Sanofi Pasteur
  • Aduro BioTech Inc.
  • Astellas Pharma Inc.
  • CSL Limited
  • Pfizer Inc.
  • Sanpower Group
  • Serum Institute of India Pvt. Ltd.

Key Topics Covered:

Chapter 1 - Introduciton

Chapter 2 - Executive Summary

Chapter 3 - Makret Overview

Chapter 4 - Cancer Vaccines Market, By Technology

Chapter 5 - Cancer Vaccines Market, By Type

Chapter 6 - Cancer Vaccines Market, By Indication

Chapter 7 - Cancer Vaccines Market, By End Use

Chapter 8 - Cancer Vaccines Market, By Geography

Chapter 9 - Company Profiles

For more information about this report visit

Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cancer Vaccines